Share Price | Ardent Health, Inc. Stock Analysis & Recommendation

Q: Is Ardent Health, Inc. overvalued or undervalued?

As of 17 October 2025, Ardent Health, Inc. has moved from an attractive to an expensive valuation grade, indicating a shift towards being overvalued. The company is currently considered overvalued based on its recent performance and valuation ratios. The price-to-earnings (P/E) ratio is not available, but the company’s current price of $14.63 is significantly higher than its 52-week low of $10.10, suggesting potential overvaluation.In comparison to the S&P 500, Ardent Health's stock has underperformed significantly over the past year, with a return of -24.97% compared to the S&P 500's 14.08%. This stark contrast reinforces the notion that the stock may be overvalued given its poor performance relative to the broader market.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

442.28 k

Shareholding (Dec 2025)

FII

1.29%

Held by 53 FIIs

DII

32.4%

Held by 17 DIIs

Promoter

60.65%

Is Ardent Health, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Ardent Health, Inc. is considered overvalued with a current price of $14.63, significantly higher than its 52-week low of $10.10, and has underperformed the S&P 500 with a return of -24.97% compared to the index's 14.08%.

View full answer

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Negative results in Jan 70

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

USD 1,347 Million (Small Cap)

P/E

6.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.40

Return on Equity

-999,999.00%

Price to Book

1.09

Revenue and Profits:

Net Sales:

1,577 Million

(Quarterly Results - Sep 2025)

Net Profit:

1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1.25%

6 Months

-32.37%

1 Year

-40.55%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Ardent Health, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.70%

EBIT Growth (5y)

27.54%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

76.88%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.68

EV to EBIT

6.09

EV to EBITDA

4.54

EV to Capital Employed

1.47

EV to Sales

0.43

PEG Ratio

Dividend Yield

ROCE (Latest)

24.08%

ROE (Latest)

27.71%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 39 Schemes (5.66%)

Foreign Institutions

Held by 53 Foreign Institutions (1.29%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -4.17% vs 9.89% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -98.75% vs 62.20% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,576.70",
          "val2": "1,645.30",
          "chgp": "-4.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "55.60",
          "val2": "176.60",
          "chgp": "-68.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "11.00",
          "val2": "11.80",
          "chgp": "-6.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.70",
          "val2": "-0.60",
          "chgp": "-1,183.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.20",
          "val2": "95.70",
          "chgp": "-98.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.40%",
          "val2": "83.40%",
          "chgp": "-7.30%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.29% vs 5.45% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 132.33% vs -51.39% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,966.10",
          "val2": "5,409.50",
          "chgp": "10.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "552.00",
          "val2": "356.60",
          "chgp": "54.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "46.60",
          "val2": "58.10",
          "chgp": "-19.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.50",
          "val2": "8.50",
          "chgp": "-82.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "299.70",
          "val2": "129.00",
          "chgp": "132.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "68.00%",
          "val2": "39.90%",
          "chgp": "2.81%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]